Loading…

Combination therapy of the granulocyte colony stimulating factor and intravenous lipid emulsion protect the hippocampus after global ischemia in rat: focusing on CA1 region

Brain stroke is one of the causes of human death and disability worldwide. Global ischemia results in the accumulation of free radicals in the neurons. It leads to histologically brain damage. The CA1 region of the hippocampus is a sensitive area for free radicals. This study investigated the combin...

Full description

Saved in:
Bibliographic Details
Published in:Metabolic brain disease 2020-08, Vol.35 (6), p.991-997
Main Authors: Rasouli, Babak, Ghahari, Laya, Safari, Manouchehr, Shahroozian, Ebrahim, Naeimi, Saeideh
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c375t-fc428d30f5cb0214341abbb6376daac32da60fcc8ce10c921a290c8142cb23fd3
cites cdi_FETCH-LOGICAL-c375t-fc428d30f5cb0214341abbb6376daac32da60fcc8ce10c921a290c8142cb23fd3
container_end_page 997
container_issue 6
container_start_page 991
container_title Metabolic brain disease
container_volume 35
creator Rasouli, Babak
Ghahari, Laya
Safari, Manouchehr
Shahroozian, Ebrahim
Naeimi, Saeideh
description Brain stroke is one of the causes of human death and disability worldwide. Global ischemia results in the accumulation of free radicals in the neurons. It leads to histologically brain damage. The CA1 region of the hippocampus is a sensitive area for free radicals. This study investigated the combined therapy of the Granulocyte colony stimulating factor (G-CSF) and the Intravenous lipid emulsion (ILE). These neuroprotective agents play a role in the regeneration of neurons. They improve the learning ability and memory in rats induced global ischemia. We divided 35 rats into five groups. The groups were sham group, ischemia group, G-CSF group, ILE group, and G-CSF plus ILE group. Ischemia was induced by occlusion of the bilateral common carotid about 10 min. The drugs applied on days 1, 3 and 7. The treated groups received subcutaneous injection of 20 μg/kg G-CSF and intravenous injection of 5 ml/kg ILE. After two weeks, the memory and learning ability of the rats was evaluated by the shuttle box. Hematoxylin and Eosin and Nissl and TUNEL stainings were used to determine the necrosis, normal and apoptotic cells. The combined therapy increased normal cells compared to the ischemia group. They decreased the number of necrotic and apoptosis cells in other groups. The combined group improved the passive avoidance test compared to the other groups. The combination therapy of G-CSF plus ILE is more effective than each alone.
doi_str_mv 10.1007/s11011-020-00579-2
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2407315459</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2422472747</sourcerecordid><originalsourceid>FETCH-LOGICAL-c375t-fc428d30f5cb0214341abbb6376daac32da60fcc8ce10c921a290c8142cb23fd3</originalsourceid><addsrcrecordid>eNp9kc1u1DAURi0EotPCC7BAltiwCVz_xQm7agQUqRIbWEeOY2dcOXawHaR5pz4knk4BiQUrW_K5537Wh9ArAu8IgHyfCQFCGqDQAAjZN_QJ2hEhWSNZK56iHXSdaCTv4QJd5nwHAEyQ_jm6YJSLjrF2h-73cRldUMXFgMvBJLUecbSnK56TCpuP-lgM1tHHcMS5uGXzlQ4ztkqXmLAKE3ahJPXThLhl7N3qJmwqlk_ONcVidHkQHty6Rq2WtWLKFpPw7OOoPHZZH8ziVBXhpMoHbKPe8mlJNeyvCU5mrrIX6JlVPpuXj-cV-v7p47f9TXP79fOX_fVto5kUpbGa025iYIUegRLOOFHjOLZMtpNSmtFJtWC17rQhoHtKFO1Bd4RTPVJmJ3aF3p69NfyPzeQyLDWh8V4FU784UA6SEcFFX9E3_6B3cUuhpqsUpVxSyWWl6JnSKeacjB3W5BaVjgOB4dTlcO5yqF0OD10OtA69flRv42KmPyO_y6sAOwO5PoXZpL-7_6P9BeT-rbg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2422472747</pqid></control><display><type>article</type><title>Combination therapy of the granulocyte colony stimulating factor and intravenous lipid emulsion protect the hippocampus after global ischemia in rat: focusing on CA1 region</title><source>Springer Nature</source><creator>Rasouli, Babak ; Ghahari, Laya ; Safari, Manouchehr ; Shahroozian, Ebrahim ; Naeimi, Saeideh</creator><creatorcontrib>Rasouli, Babak ; Ghahari, Laya ; Safari, Manouchehr ; Shahroozian, Ebrahim ; Naeimi, Saeideh</creatorcontrib><description>Brain stroke is one of the causes of human death and disability worldwide. Global ischemia results in the accumulation of free radicals in the neurons. It leads to histologically brain damage. The CA1 region of the hippocampus is a sensitive area for free radicals. This study investigated the combined therapy of the Granulocyte colony stimulating factor (G-CSF) and the Intravenous lipid emulsion (ILE). These neuroprotective agents play a role in the regeneration of neurons. They improve the learning ability and memory in rats induced global ischemia. We divided 35 rats into five groups. The groups were sham group, ischemia group, G-CSF group, ILE group, and G-CSF plus ILE group. Ischemia was induced by occlusion of the bilateral common carotid about 10 min. The drugs applied on days 1, 3 and 7. The treated groups received subcutaneous injection of 20 μg/kg G-CSF and intravenous injection of 5 ml/kg ILE. After two weeks, the memory and learning ability of the rats was evaluated by the shuttle box. Hematoxylin and Eosin and Nissl and TUNEL stainings were used to determine the necrosis, normal and apoptotic cells. The combined therapy increased normal cells compared to the ischemia group. They decreased the number of necrotic and apoptosis cells in other groups. The combined group improved the passive avoidance test compared to the other groups. The combination therapy of G-CSF plus ILE is more effective than each alone.</description><identifier>ISSN: 0885-7490</identifier><identifier>EISSN: 1573-7365</identifier><identifier>DOI: 10.1007/s11011-020-00579-2</identifier><identifier>PMID: 32458336</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Apoptosis ; Biochemistry ; Biomedical and Life Sciences ; Biomedicine ; Brain damage ; Brain injury ; Cerebral blood flow ; Cerebrospinal fluid ; Colonies ; Colony-stimulating factor ; Combination therapy ; Free radicals ; Granulocyte colony-stimulating factor ; Granulocytes ; Hippocampus ; Injection ; Intravenous administration ; Ischemia ; Learning ; Leukocytes (granulocytic) ; Lipids ; Metabolic Diseases ; Necrosis ; Neurology ; Neurons ; Neuroprotection ; Neuroprotective agents ; Neurosciences ; Occlusion ; Oncology ; Original Article ; Regeneration ; Therapy</subject><ispartof>Metabolic brain disease, 2020-08, Vol.35 (6), p.991-997</ispartof><rights>Springer Science+Business Media, LLC, part of Springer Nature 2020</rights><rights>Springer Science+Business Media, LLC, part of Springer Nature 2020.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c375t-fc428d30f5cb0214341abbb6376daac32da60fcc8ce10c921a290c8142cb23fd3</citedby><cites>FETCH-LOGICAL-c375t-fc428d30f5cb0214341abbb6376daac32da60fcc8ce10c921a290c8142cb23fd3</cites><orcidid>0000-0003-3946-8965</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32458336$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rasouli, Babak</creatorcontrib><creatorcontrib>Ghahari, Laya</creatorcontrib><creatorcontrib>Safari, Manouchehr</creatorcontrib><creatorcontrib>Shahroozian, Ebrahim</creatorcontrib><creatorcontrib>Naeimi, Saeideh</creatorcontrib><title>Combination therapy of the granulocyte colony stimulating factor and intravenous lipid emulsion protect the hippocampus after global ischemia in rat: focusing on CA1 region</title><title>Metabolic brain disease</title><addtitle>Metab Brain Dis</addtitle><addtitle>Metab Brain Dis</addtitle><description>Brain stroke is one of the causes of human death and disability worldwide. Global ischemia results in the accumulation of free radicals in the neurons. It leads to histologically brain damage. The CA1 region of the hippocampus is a sensitive area for free radicals. This study investigated the combined therapy of the Granulocyte colony stimulating factor (G-CSF) and the Intravenous lipid emulsion (ILE). These neuroprotective agents play a role in the regeneration of neurons. They improve the learning ability and memory in rats induced global ischemia. We divided 35 rats into five groups. The groups were sham group, ischemia group, G-CSF group, ILE group, and G-CSF plus ILE group. Ischemia was induced by occlusion of the bilateral common carotid about 10 min. The drugs applied on days 1, 3 and 7. The treated groups received subcutaneous injection of 20 μg/kg G-CSF and intravenous injection of 5 ml/kg ILE. After two weeks, the memory and learning ability of the rats was evaluated by the shuttle box. Hematoxylin and Eosin and Nissl and TUNEL stainings were used to determine the necrosis, normal and apoptotic cells. The combined therapy increased normal cells compared to the ischemia group. They decreased the number of necrotic and apoptosis cells in other groups. The combined group improved the passive avoidance test compared to the other groups. The combination therapy of G-CSF plus ILE is more effective than each alone.</description><subject>Apoptosis</subject><subject>Biochemistry</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Brain damage</subject><subject>Brain injury</subject><subject>Cerebral blood flow</subject><subject>Cerebrospinal fluid</subject><subject>Colonies</subject><subject>Colony-stimulating factor</subject><subject>Combination therapy</subject><subject>Free radicals</subject><subject>Granulocyte colony-stimulating factor</subject><subject>Granulocytes</subject><subject>Hippocampus</subject><subject>Injection</subject><subject>Intravenous administration</subject><subject>Ischemia</subject><subject>Learning</subject><subject>Leukocytes (granulocytic)</subject><subject>Lipids</subject><subject>Metabolic Diseases</subject><subject>Necrosis</subject><subject>Neurology</subject><subject>Neurons</subject><subject>Neuroprotection</subject><subject>Neuroprotective agents</subject><subject>Neurosciences</subject><subject>Occlusion</subject><subject>Oncology</subject><subject>Original Article</subject><subject>Regeneration</subject><subject>Therapy</subject><issn>0885-7490</issn><issn>1573-7365</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9kc1u1DAURi0EotPCC7BAltiwCVz_xQm7agQUqRIbWEeOY2dcOXawHaR5pz4knk4BiQUrW_K5537Wh9ArAu8IgHyfCQFCGqDQAAjZN_QJ2hEhWSNZK56iHXSdaCTv4QJd5nwHAEyQ_jm6YJSLjrF2h-73cRldUMXFgMvBJLUecbSnK56TCpuP-lgM1tHHcMS5uGXzlQ4ztkqXmLAKE3ahJPXThLhl7N3qJmwqlk_ONcVidHkQHty6Rq2WtWLKFpPw7OOoPHZZH8ziVBXhpMoHbKPe8mlJNeyvCU5mrrIX6JlVPpuXj-cV-v7p47f9TXP79fOX_fVto5kUpbGa025iYIUegRLOOFHjOLZMtpNSmtFJtWC17rQhoHtKFO1Bd4RTPVJmJ3aF3p69NfyPzeQyLDWh8V4FU784UA6SEcFFX9E3_6B3cUuhpqsUpVxSyWWl6JnSKeacjB3W5BaVjgOB4dTlcO5yqF0OD10OtA69flRv42KmPyO_y6sAOwO5PoXZpL-7_6P9BeT-rbg</recordid><startdate>20200801</startdate><enddate>20200801</enddate><creator>Rasouli, Babak</creator><creator>Ghahari, Laya</creator><creator>Safari, Manouchehr</creator><creator>Shahroozian, Ebrahim</creator><creator>Naeimi, Saeideh</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7U7</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-3946-8965</orcidid></search><sort><creationdate>20200801</creationdate><title>Combination therapy of the granulocyte colony stimulating factor and intravenous lipid emulsion protect the hippocampus after global ischemia in rat: focusing on CA1 region</title><author>Rasouli, Babak ; Ghahari, Laya ; Safari, Manouchehr ; Shahroozian, Ebrahim ; Naeimi, Saeideh</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c375t-fc428d30f5cb0214341abbb6376daac32da60fcc8ce10c921a290c8142cb23fd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Apoptosis</topic><topic>Biochemistry</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Brain damage</topic><topic>Brain injury</topic><topic>Cerebral blood flow</topic><topic>Cerebrospinal fluid</topic><topic>Colonies</topic><topic>Colony-stimulating factor</topic><topic>Combination therapy</topic><topic>Free radicals</topic><topic>Granulocyte colony-stimulating factor</topic><topic>Granulocytes</topic><topic>Hippocampus</topic><topic>Injection</topic><topic>Intravenous administration</topic><topic>Ischemia</topic><topic>Learning</topic><topic>Leukocytes (granulocytic)</topic><topic>Lipids</topic><topic>Metabolic Diseases</topic><topic>Necrosis</topic><topic>Neurology</topic><topic>Neurons</topic><topic>Neuroprotection</topic><topic>Neuroprotective agents</topic><topic>Neurosciences</topic><topic>Occlusion</topic><topic>Oncology</topic><topic>Original Article</topic><topic>Regeneration</topic><topic>Therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rasouli, Babak</creatorcontrib><creatorcontrib>Ghahari, Laya</creatorcontrib><creatorcontrib>Safari, Manouchehr</creatorcontrib><creatorcontrib>Shahroozian, Ebrahim</creatorcontrib><creatorcontrib>Naeimi, Saeideh</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Psychology Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Metabolic brain disease</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rasouli, Babak</au><au>Ghahari, Laya</au><au>Safari, Manouchehr</au><au>Shahroozian, Ebrahim</au><au>Naeimi, Saeideh</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Combination therapy of the granulocyte colony stimulating factor and intravenous lipid emulsion protect the hippocampus after global ischemia in rat: focusing on CA1 region</atitle><jtitle>Metabolic brain disease</jtitle><stitle>Metab Brain Dis</stitle><addtitle>Metab Brain Dis</addtitle><date>2020-08-01</date><risdate>2020</risdate><volume>35</volume><issue>6</issue><spage>991</spage><epage>997</epage><pages>991-997</pages><issn>0885-7490</issn><eissn>1573-7365</eissn><abstract>Brain stroke is one of the causes of human death and disability worldwide. Global ischemia results in the accumulation of free radicals in the neurons. It leads to histologically brain damage. The CA1 region of the hippocampus is a sensitive area for free radicals. This study investigated the combined therapy of the Granulocyte colony stimulating factor (G-CSF) and the Intravenous lipid emulsion (ILE). These neuroprotective agents play a role in the regeneration of neurons. They improve the learning ability and memory in rats induced global ischemia. We divided 35 rats into five groups. The groups were sham group, ischemia group, G-CSF group, ILE group, and G-CSF plus ILE group. Ischemia was induced by occlusion of the bilateral common carotid about 10 min. The drugs applied on days 1, 3 and 7. The treated groups received subcutaneous injection of 20 μg/kg G-CSF and intravenous injection of 5 ml/kg ILE. After two weeks, the memory and learning ability of the rats was evaluated by the shuttle box. Hematoxylin and Eosin and Nissl and TUNEL stainings were used to determine the necrosis, normal and apoptotic cells. The combined therapy increased normal cells compared to the ischemia group. They decreased the number of necrotic and apoptosis cells in other groups. The combined group improved the passive avoidance test compared to the other groups. The combination therapy of G-CSF plus ILE is more effective than each alone.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>32458336</pmid><doi>10.1007/s11011-020-00579-2</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0003-3946-8965</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0885-7490
ispartof Metabolic brain disease, 2020-08, Vol.35 (6), p.991-997
issn 0885-7490
1573-7365
language eng
recordid cdi_proquest_miscellaneous_2407315459
source Springer Nature
subjects Apoptosis
Biochemistry
Biomedical and Life Sciences
Biomedicine
Brain damage
Brain injury
Cerebral blood flow
Cerebrospinal fluid
Colonies
Colony-stimulating factor
Combination therapy
Free radicals
Granulocyte colony-stimulating factor
Granulocytes
Hippocampus
Injection
Intravenous administration
Ischemia
Learning
Leukocytes (granulocytic)
Lipids
Metabolic Diseases
Necrosis
Neurology
Neurons
Neuroprotection
Neuroprotective agents
Neurosciences
Occlusion
Oncology
Original Article
Regeneration
Therapy
title Combination therapy of the granulocyte colony stimulating factor and intravenous lipid emulsion protect the hippocampus after global ischemia in rat: focusing on CA1 region
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T02%3A19%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Combination%20therapy%20of%20the%20granulocyte%20colony%20stimulating%20factor%20and%20intravenous%20lipid%20emulsion%20protect%20the%20hippocampus%20after%20global%20ischemia%20in%20rat:%20focusing%20on%20CA1%20region&rft.jtitle=Metabolic%20brain%20disease&rft.au=Rasouli,%20Babak&rft.date=2020-08-01&rft.volume=35&rft.issue=6&rft.spage=991&rft.epage=997&rft.pages=991-997&rft.issn=0885-7490&rft.eissn=1573-7365&rft_id=info:doi/10.1007/s11011-020-00579-2&rft_dat=%3Cproquest_cross%3E2422472747%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c375t-fc428d30f5cb0214341abbb6376daac32da60fcc8ce10c921a290c8142cb23fd3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2422472747&rft_id=info:pmid/32458336&rfr_iscdi=true